Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders. (Q37965552)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Sinda Zarrouk Mahjoub

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Josef Finsterer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

7 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Metabolism & Toxicology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

71-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

Central nervous system manifestations of mitochondrial disorders

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Epileptic phenotypes associated with mitochondrial disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

"Erratic" complex partial status epilepticus as a presenting feature of MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome: experience with 87 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

A study of EEG and epilepsy profile in Wolf-Hirschhorn syndrome and considerations regarding its correlation with other chromosomal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Efficacy of lamotrigine in disabling myoclonus in a patient with an mtDNA A3243G mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Infantile Spasms with Basal Ganglia MRI Hypersignal May Reveal Mitochondrial Disorder Due to T8993G MT DNA Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Pathophysiology and management of syncope in Kearns-Sayre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Epilepsy in Wolf-Hirschhorn syndrome (4p-).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

A case of Ohtahara syndrome with mitochondrial respiratory chain complex I deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

The ketogenic diet and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Ketamine successfully terminates malignant status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Atypical presentation of VLCAD deficiency associated with a novel ACADVL splicing mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Evidence that Alpers-Huttenlocher syndrome could be a mitochondrial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Valproate-induced liver failure in one of two siblings with Alpers disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Antimyoclonic effect of levetiracetam in MERRF syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Structural determinants for branched-chain aminotransferase isozyme-specific inhibition by the anticonvulsant drug gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

The effect of antiepileptic drugs on mitochondrial activity: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Cytoprotection by lithium and valproate varies between cell types and cellular stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Neuroprotective effects of zonisamide target astrocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

The mechanism of neuroprotection by topiramate in an animal model of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Alpers syndrome: progressive neuronal degeneration of children with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Therapeutic safety monitoring: what to look for and when to look for it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Valproic acid affects membrane trafficking and cell-wall integrity in fission yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Effects of anticonvulsant and convulsant drugs on the ATPase activities of synaptosomes and their components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Diphenylhydantoin suppresses glucose-induced insulin release by decreasing cytoplasmic H+ concentration in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

The latest on infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

In vivo and in vitro effects of phenytoin (PHT) on ATPases and [14C]-PHT binding in synaptosomes and mitochondria from rat cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.644535

10.1517/17425255.2012.644535

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149023%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference